Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001193125-25-281215·Arcturus Therapeutics Holdings Inc.
Schedule 13G ownership disclosure
Arcturus Therapeutics Holdings Inc
Common Stock, par value $0.001 per share · CUSIP: 03969T109
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Balyasny Asset Management L.P.
Shares: 2,183,985 · Class: 8.04%
- BAM GP LLC
Shares: 2,183,985 · Class: 8.04%
- Balyasny Asset Management Holdings LP
Shares: 2,183,985 · Class: 8.04%
- Dames GP LLC
Shares: 2,183,985 · Class: 8.04%
- Dmitry Balyasny
Shares: 2,183,985 · Class: 8.04%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-281215
- Form type
- SCHEDULE 13G
- Filer
- Arcturus Therapeutics Holdings Inc.
- CIK
- CIK 1768224
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership